Description

2,3-Dihydro-3-Phenyl-1,5-Benzoxazepin-4(5H)-One is a specialized heterocyclic organic compound featuring a benzoxazepine core structure. This molecule serves as a critical pharmaceutical intermediate and research chemical for the development of novel active ingredients. It is primarily utilized by R&D chemists and process development scientists in the pharmaceutical and agrochemical sectors. The compound's unique fused-ring system makes it a valuable scaffold for creating molecules with potential biological activity.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of potential drug candidates targeting central nervous system (CNS) disorders, anxiety, or depression.
• Agrochemical Research: Used as a precursor in the development of new herbicides or fungicides, leveraging its heterocyclic structure.
• Organic Synthesis Scaffold: Serves as a versatile core structure for medicinal chemistry programs, enabling the exploration of structure-activity relationships (SAR).
• Chemical Reference Standard: Employed in analytical laboratories for method development, calibration, and quality control of related substances.
• Academic & Institutional Research: Used in universities and research institutes for studying heterocyclic chemistry, reaction mechanisms, and novel synthetic pathways.

Basic Information

Product Name	2,3-Dihydro-3-Phenyl-1,5-Benzoxazepin-4(5H)-One
CAS No.	33255-29-7
Molecular Formula	C16H13NO2
Molecular Weight	251.28 g/mol
Synonyms	3-Phenyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one; 4(5H)-Benzoxazepinone, 2,3-dihydro-3-phenyl-; 3-Phenyl-2,3,4,5-tetrahydro-1,5-benzoxazepin-4-one; 1,5-Benzoxazepin-4(5H)-one, 2,3-dihydro-3-phenyl-; Benzoxazepine derivative 33255-29-7
EINECS	Contact for details

Quality Control

Our 2,3-Dihydro-3-Phenyl-1,5-Benzoxazepin-4(5H)-One is produced under a strict quality management system. Every batch undergoes comprehensive analytical testing to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing purity by HPLC, identification by spectroscopic methods, and impurity profiles are provided and available upon request. We adhere to cGMP principles for the manufacture of pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at controlled room temperature (15-25°C). Keep the container tightly sealed to protect from moisture. Store away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Melting Point	Contact for details
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.